Panos Chrysanthopoulos

Chief Development Officer at Morphocell

Speaker

Panos is a leading expert in iPSC-derived cell therapy development, CMC strategy, and bioprocess optimization, with extensive experience in scaling up manufacturing processes for clinical applications. As Chief Development Officer at Morphocell Technologies, he oversees Product Development, CMC, and Technical Operations, driving the clinical readiness of innovative cell-based therapies. With a background in in Systems Biology, Quality by Design (QbD) based process development & characterization, and analytical development, Panos has played a pivotal role in shaping scalable, high-efficiency biomanufacturing strategies. His experience spans leadership roles at weCANdev Consulting Group, Artisan Biotechnologies, BlueRock Therapeutics, and CCRM, where he has built and led high-performing teams, managed CDMO collaborations, and spearheaded technology transfers into GMP manufacturing. Panos is dedicated to bridging innovation with clinical translation, ensuring next-generation therapies reach patients efficiently and effectively.